Delivery Order SPE2DB22D1202-SPE2DB24FUSG2
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,855.01 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ORILISSA 150 MG TABLET 7S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $20,090.38 firm fixed price delivery order is for the supply of 4,564,170 units of the pharmaceutical product ORILISSA 150 MG TABLET 7S. The contract has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation mentioned. This delivery order is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ORILISSA 150 MG TABLET 7S. The contract, valued at $4,051.04, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 14, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
- This is a $12,191.74 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of the medication ORILISSA 150 MG TABLET 7S. The contract has a completion date of June 18, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (Corporate Office Division) for the supply of the pharmaceutical product ORILISSA 150 MG TABLET 7S. The contract has a ceiling value of $2,190.64 and an ultimate completion date of July 12, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen Drug Corp, a subsidiary of the large pharmaceutical distribution company...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company, to provide ORILISSA 150 MG TABLET 7S, a pharmaceutical product, in support of military treatment programs and facilities. The contract has a ceiling value of $3,270.86 and a period of performance through March 26, 2024. AmerisourceBergen Drug Corp holds an Indefinite...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORILISSA 150 MG TABLET 7S, a medication, with a ceiling value of $12,606.64 and a performance period through June 6, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation. The $2,341.16 firm fixed price delivery order is for the supply of ORILISSA 200 MG TABLET 14S, a pharmaceutical product. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,756.28 firm fixed-price delivery order is for the supply of ORILISSA 150 MG TABLET 7S, a prescription medication. The contract has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $11,595.78, is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of October 24, 2024 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUSG2Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product ORILISSA 150 MG TABLET 7S. The contract has a potential value of $2,115.75 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any set-aside designation. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide in support of the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 3/1/24 |